Allakos (ALLK) Stock Chart & Stock Price History → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free ALLK Stock Alerts $1.20 -0.09 (-6.98%) (As of 05/10/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Allakos Stock Price Performance5 Day Performance-2.04%1 Month Performance+8.11%3 Month Performance-13.67%6 Month Performance-32.96%Year-To-Date Performance-56.04%1 Year Performance-73.51% Receive ALLK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Allakos and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. For one main reason.In answer to this issue, we have released a Special Report to the public. ALLK Stock Chart for Sunday, May, 12, 2024 ALLK Chart by TradingView Allakos Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/10/2024$1.29$1.20-6.98%$1.24$1.17534,549 shs$106.25 million05/09/2024$1.26$1.29+2.38%$1.30$1.21347,049 shs$114.22 million05/08/2024$1.23$1.26+2.86%$1.30$1.18528,665 shs$111.56 million05/07/2024$1.17$1.23+4.70%$1.27$1.14356,559 shs$108.46 million05/06/2024$1.16$1.17+0.86%$1.24$1.14671,150 shs$103.59 million05/03/2024$1.10$1.16+5.45%$1.17$1.11181,873 shs$102.71 million Get the Latest News and Ratings for ALLK and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Allakos and its competitors with MarketBeat's FREE daily newsletter. 05/02/2024$1.13$1.10-2.65%$1.17$1.08250,198 shs$97.39 million05/01/2024$1.05$1.13+7.62%$1.18$1.06427,682 shs$100.05 million04/30/2024$1.10$1.05-4.55%$1.10$1.04251,806 shs$92.97 million04/29/2024$1.02$1.10+7.84%$1.14$1.02631,624 shs$97.40 million04/26/2024$1.01$1.02+0.99%$1.03$0.99431,150 shs$90.31 million04/25/2024$1.02$1.01-0.98%$1.04$0.98394,456 shs$88.75 million04/24/2024$1.05$1.02-2.86%$1.10$1.02246,068 shs$89.63 million04/23/2024$1.06$1.05-0.94%$1.10$1.05266,527 shs$92.26 million04/22/2024$1.07$1.06-0.93%$1.08$1.03279,226 shs$93.14 million04/19/2024$1.06$1.07+0.94%$1.09$1.02415,801 shs$94.02 million04/18/2024$1.06$1.06$1.12$1.03424,606 shs$93.14 million04/17/2024$1.05$1.06+0.95%$1.08$1.03336,696 shs$93.14 million04/16/2024$1.08$1.05-2.78%$1.10$1.00302,815 shs$92.26 million04/15/2024$1.11$1.08-2.70%$1.14$1.04640,303 shs$94.90 million04/12/2024$1.21$1.11-8.26%$1.21$1.10409,664 shs$97.54 million04/11/2024$1.16$1.21+4.31%$1.22$1.15354,630 shs$106.33 million04/10/2024$1.20$1.16-3.33%$1.18$1.10459,306 shs$101.93 million04/09/2024$1.13$1.20+6.19%$1.21$1.13356,726 shs$105.44 million04/08/2024$1.19$1.13-5.04%$1.18$1.11559,644 shs$99.29 million04/05/2024$1.23$1.19-3.25%$1.22$1.17503,073 shs$104.57 million04/04/2024$1.28$1.23-3.91%$1.30$1.21486,058 shs$108.08 million04/03/2024$1.24$1.28+3.23%$1.31$1.20513,785 shs$112.47 million04/02/2024$1.22$1.24+1.64%$1.26$1.18414,679 shs$108.96 million04/01/2024$1.26$1.22-3.17%$1.28$1.18591,521 shs$107.21 million03/29/2024$1.26$1.26$1.32$1.26525,242 shs$110.72 million03/28/2024$1.28$1.26-1.56%$1.32$1.26524,912 shs$110.72 million03/27/2024$1.29$1.28-0.78%$1.36$1.27337,765 shs$112.47 million03/26/2024$1.32$1.29-2.27%$1.35$1.28371,897 shs$113.36 million03/25/2024$1.35$1.32-2.22%$1.41$1.32492,839 shs$115.99 million03/22/2024$1.29$1.35+4.65%$1.37$1.27517,308 shs$118.63 million03/21/2024$1.31$1.29-1.53%$1.36$1.25611,149 shs$113.36 million03/20/2024$1.25$1.31+4.80%$1.33$1.21510,915 shs$115.11 million03/19/2024$1.23$1.25+1.63%$1.31$1.21828,463 shs$109.84 million03/18/2024$1.31$1.23-6.11%$1.28$1.20859,589 shs$107.60 millionCollapse of the Petrodollar (Ad)The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar. For one main reason.In answer to this issue, we have released a Special Report to the public.03/15/2024$1.31$1.31+0.38%$1.32$1.25682,344 shs$114.60 million03/14/2024$1.40$1.31-6.45%$1.39$1.25655,838 shs$114.16 million03/13/2024$1.33$1.40+4.89%$1.42$1.34597,941 shs$122.04 million03/12/2024$1.44$1.33-7.64%$1.50$1.29498,363 shs$116.35 million03/11/2024$1.43$1.44+0.70%$1.51$1.39624,299 shs$125.97 million03/08/2024$1.32$1.43+8.33%$1.49$1.35884,830 shs$125.10 million03/07/2024$1.29$1.32+2.33%$1.33$1.24835,343 shs$115.47 million03/06/2024$1.40$1.29-7.86%$1.44$1.27973,538 shs$112.85 million03/05/2024$1.45$1.40-3.11%$1.49$1.38445,726 shs$122.47 million03/04/2024$1.64$1.45-11.89%$1.66$1.44547,137 shs$126.41 million03/01/2024$1.48$1.64+10.81%$1.69$1.481.04 million shs$143.47 million02/29/2024$1.55$1.48-4.52%$1.61$1.44549,072 shs$129.47 million02/28/2024$1.60$1.55-3.13%$1.62$1.55704,822 shs$135.59 million02/27/2024$1.46$1.60+9.59%$1.62$1.47903,932 shs$139.97 million02/26/2024$1.36$1.46+7.35%$1.53$1.35942,162 shs$127.72 million02/23/2024$1.34$1.36+1.49%$1.38$1.30417,006 shs$118.97 million02/22/2024$1.29$1.34+3.88%$1.39$1.27656,323 shs$117.22 million02/21/2024$1.22$1.29+5.74%$1.30$1.22565,737 shs$112.85 million02/20/2024$1.25$1.22-2.40%$1.29$1.221.10 million shs$106.73 million02/19/2024$1.25$1.25$1.29$1.201.77 million shs$109.35 million02/16/2024$1.27$1.25-1.57%$1.29$1.201.77 million shs$109.35 million02/15/2024$1.28$1.27-0.39%$1.30$1.231.00 million shs$111.10 million02/14/2024$1.27$1.28+0.39%$1.30$1.22804,973 shs$111.54 million02/13/2024$1.39$1.27-8.63%$1.34$1.25792,271 shs$111.10 million02/12/2024$1.34$1.39+3.73%$1.50$1.32709,630 shs$121.59 million Related Companies: Cyteir Therapeutics Stock Chart Citius Pharmaceuticals Stock Chart Cue Biopharma Stock Chart Assertio Stock Chart PMV Pharmaceuticals Stock Chart Genelux Stock Chart Relmada Therapeutics Stock Chart IO Biotech Stock Chart Rezolute Stock Chart Societal CDMO Stock Chart Receive ALLK Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Allakos and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALLK) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsCollapse of the Petrodollar Colonial MetalsGold Set to EXPLODE!Gold Safe ExchangeShocking: One AI startup's revenue could surge 4,735%Manward Press[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allakos Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.